Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Stein

Showing results (231-240 of 342) with videos related to

Pageof 35
Sort By:
Investigational New Drugs|December 2, 2015
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumorsManik Amin, Susan E Minton, Patricia M LoRusso, et al.
Cancer Chemotherapy and Pharmacology|January 14, 2014
A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignanciesJustine Yang Bruce, Jill M Kolesar, Hans Hammers, et al.
JCO Oncology Practice|October 30, 2024
Telephone Survey-Reported Perceptions of Telehealth Visits Among Black and Non-Black Patients Diagnosed With CancerIlona Fridman, Christine Neslund-Dudas, Lauren C J Barrow, et al.
Journal of Geophysical Research. Planets|March 3, 2018
Sedimentary processes of the Bagnold Dunes: Implications for the eolian rock record of MarsR C Ewing, M G A Lapotre, K W Lewis, et al.
The Prostate|January 4, 2020
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapyJessica E Hawley, Samuel Pan, William D Figg, et al.
Journal of Adolescent and Young Adult Oncology|April 28, 2025
All Hands on Deck: A Novel Collaborative Model for Care Provision in Young Adult OncologyJulie S W Childers, Jacob N Stein, Catherine Swift, et al.
European Urology|December 24, 2014
A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802Robert S DiPaola, Yu-Hui Chen, Glenn J Bubley, et al.
JCO Oncology Practice|January 28, 2026
Comparing Outcomes: In-Person and Telehealth Oncology VisitsIlona Fridman, Christine Neslund-Dudas, Lauren Jordan Barrow, et al.
Current Urology Reports|April 10, 2025
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active SurveillanceBenjamin I Joffe, John R Christin, Clémentine Le Coz, et al.
Biology Open|July 23, 2021
20-hydroxyecdysone (20E) signaling regulates amnioserosa morphogenesis during Drosophila dorsal closure: EcR modulates gene expression in a complex with the AP-1 subunit, JunByoungjoo Yoo, Hae-Yoon Kim, Xi Chen, et al.
Pageof 35

Showing results (231-240 of 342) with videos related to

Sort By:
Pageof 35
Investigational New Drugs|December 2, 2015
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumorsManik Amin, Susan E Minton, Patricia M LoRusso, et al.
Cancer Chemotherapy and Pharmacology|January 14, 2014
A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignanciesJustine Yang Bruce, Jill M Kolesar, Hans Hammers, et al.
JCO Oncology Practice|October 30, 2024
Telephone Survey-Reported Perceptions of Telehealth Visits Among Black and Non-Black Patients Diagnosed With CancerIlona Fridman, Christine Neslund-Dudas, Lauren C J Barrow, et al.
Journal of Geophysical Research. Planets|March 3, 2018
Sedimentary processes of the Bagnold Dunes: Implications for the eolian rock record of MarsR C Ewing, M G A Lapotre, K W Lewis, et al.
The Prostate|January 4, 2020
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapyJessica E Hawley, Samuel Pan, William D Figg, et al.
Journal of Adolescent and Young Adult Oncology|April 28, 2025
All Hands on Deck: A Novel Collaborative Model for Care Provision in Young Adult OncologyJulie S W Childers, Jacob N Stein, Catherine Swift, et al.
European Urology|December 24, 2014
A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802Robert S DiPaola, Yu-Hui Chen, Glenn J Bubley, et al.
JCO Oncology Practice|January 28, 2026
Comparing Outcomes: In-Person and Telehealth Oncology VisitsIlona Fridman, Christine Neslund-Dudas, Lauren Jordan Barrow, et al.
Current Urology Reports|April 10, 2025
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active SurveillanceBenjamin I Joffe, John R Christin, Clémentine Le Coz, et al.
Biology Open|July 23, 2021
20-hydroxyecdysone (20E) signaling regulates amnioserosa morphogenesis during Drosophila dorsal closure: EcR modulates gene expression in a complex with the AP-1 subunit, JunByoungjoo Yoo, Hae-Yoon Kim, Xi Chen, et al.
Pageof 35